ClinicalTrials.Veeva

Menu

Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus

H

Hôpital Armand Trousseau

Status

Completed

Conditions

Pain

Treatments

Drug: Remifentanil
Device: TCI
Drug: propofol
Device: Algiscan
Procedure: Tetanic stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT02595476
Anesthésie Trousseau 002

Details and patient eligibility

About

A standardized tetanic stimulation is applied to patients under propofol-remifentanil TCI, in a cross-over fashion, at two different levels of anesthesia monitored by the BIS: BIS 25 and BIS 55. Remifentanil target remains constant during the whole study period (1 ng/ml). Pupillary reflex dilation is recorded after each stimulation.

Enrollment

12 patients

Sex

All

Ages

10 to 20 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA 1-2
  • scheduled for an idiopathic scoliosis surgical correction

Exclusion criteria

  • Ophtalmologic pathology
  • Neurologic or muscular pathology
  • Metabolic pathology
  • Chronic pain

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 2 patient groups

BIS 55
Experimental group
Description:
1. Induction: TCI propofol (6 µg/ml) - remifentanil (4 ng/ml) Atracurium IV (0.5 mg/kg) 2. Orotracheal Intubation 3. Remifentanil target decreased to 1 ng/ml 4. Propofol target adjustment to reach BIS 55 5. 10 minutes steady state 6. Tetanic stimulation (ulnar nerve): 100 Hz, 60 milliamps, 5 seconds 7. Pupillary dilation recording (videopupillometer Algiscan)
Treatment:
Device: TCI
Drug: Remifentanil
Device: Algiscan
Procedure: Tetanic stimulation
Drug: propofol
BIS 25
Active Comparator group
Description:
1. Induction: TCI propofol (6 µg/ml) - remifentanil (4 ng/ml) Atracurium IV (0.5 mg/kg) 2. Orotracheal Intubation 3. Remifentanil target decreased to 1 ng/ml 4. Propofol target adjustment to reach BIS 25 5. 10 minutes steady state 6. Tetanic stimulation (ulnar nerve): 100 Hz, 60 milliamps, 5 seconds 7. Pupillary dilation recording (videopupillometer Algiscan)
Treatment:
Device: TCI
Drug: Remifentanil
Device: Algiscan
Procedure: Tetanic stimulation
Drug: propofol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems